BRAIN Biotech AG (HAM:BNN) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jul. 07, 2026)


HAM:BNN BRAIN Biotech AG HAM:BNN
66 GF Score
Price €2.74
GF Value €2.48
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is BRAIN Biotech AG Float Percentage Of Total Shares Outstanding?

BRAIN Biotech AG HAM:BNN -4.20% 66 Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 07, 2026. GuruFocus rates HAM:BNN with a GF Score™ of 66/100 and a GF Value™ of €2.48 (Fairly Valued). The stock has 2 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, BRAIN Biotech AG's float shares is 0.00 Mil. BRAIN Biotech AG's total shares outstanding is 21.85 Mil. BRAIN Biotech AG's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, BRAIN Biotech AG's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, BRAIN Biotech AG's Institutional Ownership is 2.66%.

HAM:BNN
66GF Score
BRAIN Biotech AG HAM:BNN
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BRAIN Biotech AG Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

BRAIN Biotech AG's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/21.85
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
BRAIN Biotech AG (HAM:BNN) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jul. 07, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on BRAIN Biotech AG and its competitors.
Is BRAIN Biotech AG's Float Percentage Of Total Shares Outstanding too high?
BRAIN Biotech AG's current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, BRAIN Biotech AG has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BRAIN Biotech AG's Float Percentage Of Total Shares Outstanding compare to LIN and SHW?
BRAIN Biotech AG's Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Chemicals company?
A good Float Percentage Of Total Shares Outstanding depends on the Chemicals industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on BRAIN Biotech AG and its competitors. BRAIN Biotech AG's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BRAIN Biotech AG stock overvalued right now?
Based on GuruFocus' analysis, BRAIN Biotech AG (HAM:BNN) is currently considered Fairly Valued. The stock's GF Value™ is €2.48, compared to a current price of €2.74 — trading 10.5% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. BRAIN Biotech AG's overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For BRAIN Biotech AG (HAM:BNN), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BRAIN Biotech AG (HAM:BNN) Overvalued in 2026?

Based on GuruFocus' analysis, BRAIN Biotech AG stock appears to be overvalued. The current stock price of €2.74 is trading 10.5% above its estimated GF Value™ of €2.48. GuruFocus considers BRAIN Biotech AG to be Fairly Valued.

Key valuation signals for HAM:BNN:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: €2.48 vs. price of €2.74 (10.5% above fair value)
  • GF Score™: 66/100 with 2 warning signs

No single metric tells the full story. See the HAM:BNN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BRAIN Biotech AG Business Description

Other Exchanges 0RFI:UKBNN:Germany
Address Darmstadter Strasse 34-36, Zwingenberg, BW, DEU, 64673
BRAIN Biotech AG is an industrial biotechnology specialist focused on enzyme technology, microbial production strains, and bioprocess design to enable bio-based innovations. The Group conducts research, development, and production for client specifications and its own product portfolio, supporting customers in the food and beverage, chemical, and life sciences industries with solutions that enhance productivity, efficiency, and sustainability. Its operations are organized into two segments: BRAIN Biocatalysts, which develops, produces, and distributes specialty enzymes, microorganisms, and ingredients and generates the majority of revenue, and BRAIN BioIncubator, which focuses on development projects. The company operates in Germany and other countries.
66GF Score

Get the complete analysis for HAM:BNN

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.74
Price
€2.48
GF Value